Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical organizations, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably secure for use - and failure to complete so might be grounds for compensation. Our lawyers are functioning tough to get those hurt by the drug the compensation they're entitled to.













image class="left" url="http://media1.picsearch.com/is?IRZLmylDSpLyBTpHTom0Osr0NSJ_XXWHyw0FRo22lC0&height=224"Even though bleeding is actually a common complication associated with anticoagulants, it has been alleged that Xarelto is a lot more harmful than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, inside the event of an emergency, patients may be at risk for irreversible bleeding difficulties, such as life-threatening internal and gastrointestinal hemorrhaging.













If you or a loved 1 suffered a critical bleeding occasion following taking Xarelto, you may have legal recourse. For far more info, contact us right now to have your case reviewed, cost-free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in instances of death, funeral expenditures. Moreover, they're looking for punitive damages, that are generally awarded to punish the defendant and deter other companies from acting similarly.






Why Are Lawsuits Becoming Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a secure anticoagulant option.






Doctors and health-related staff were not properly made aware of methods to stabilize and treat a bula do xarelto 15mg user inside the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.






Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.













Visit this page for far more details on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













image class="left" url="http://media3.picsearch.com/is?RcGfPeaRsMI4EHKO6c8Oei-upWX7miNta4qpbodw0LQ&height=202"The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki